APhA OTC guide
This article was originally published in The Tan Sheet
Thirteenth edition of the Handbook of Nonprescription Drugs "emphasizes patient assessment, triage, self-care options, product evaluation and comparison, patient counseling and evaluation of patient outcomes," American Pharmaceutical Association says. Book's features include section on alternative remedies where applicable, tables of major trade name products, treatment algorithms and case studies; appendices include FDA pregnancy risk categories for selected OTCs, supplements. Handbook, which last was updated in 2000, can be purchased from APhA for $135...
You may also be interested in...
Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty
The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.